2SEVENTY BIO INC's ticker is and the CUSIP is 901384107. A total of 128 filers reported holding 2SEVENTY BIO INC in Q4 2021. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $5,449 | -63.1% | 1,389,953 | -4.6% | 0.05% | -56.7% |
Q2 2023 | $14,749 | +40.5% | 1,457,390 | +41.6% | 0.12% | +37.9% |
Q1 2023 | $10,496 | +23.5% | 1,029,040 | +13.4% | 0.09% | -29.3% |
Q4 2022 | $8,500 | -99.8% | 907,135 | +270.6% | 0.12% | +161.7% |
Q3 2022 | $3,561,000 | -0.0% | 244,745 | -9.3% | 0.05% | +6.8% |
Q2 2022 | $3,562,000 | -10.6% | 269,879 | +15.5% | 0.04% | -12.0% |
Q1 2022 | $3,985,000 | +20.6% | 233,585 | +81.2% | 0.05% | +47.1% |
Q4 2021 | $3,303,000 | – | 128,886 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Newtyn Management, LLC | 1,587,805 | $27,088,000 | 6.49% |
CHI Advisors LLC | 819,672 | $13,984,000 | 5.95% |
Madison Avenue Partners, LP | 896,972 | $15,302,342,000 | 2.86% |
Bain Capital Life Sciences Investors, LLC | 1,408,901 | $24,036,000 | 2.33% |
EcoR1 Capital, LLC | 3,495,943 | $59,641,000 | 1.87% |
TANG CAPITAL MANAGEMENT LLC | 300,000 | $5,118,000 | 1.02% |
CVI Holdings, LLC | 819,672 | $13,984,000 | 0.92% |
ARMISTICE CAPITAL, LLC | 2,000,000 | $34,120,000 | 0.66% |
Altium Capital Management LP | 115,000 | $1,962,000 | 0.66% |
Casdin Capital, LLC | 614,754 | $10,488,000 | 0.47% |